Literature DB >> 21381518

Immunohistochemistry and pathology of multiple Great Lakes fish from mortality events associated with viral hemorrhagic septicemia virus type IVb.

L Al-Hussinee1, S Lord, R M W Stevenson, R N Casey, G H Groocock, K L Britt, K H Kohler, G A Wooster, R G Getchell, P R Bowser, J S Lumsden.   

Abstract

A novel viral hemorrhagic septicemia virus (VHSV) (genotype IVb) has been isolated from mortality events in a range of wild freshwater fish from the Great Lakes since 2005. In 2005 and 2006, numerous new freshwater host species (approximately 90 fish from 12 different species) were confirmed to have VHSV by cell culture and reverse transcriptase polymerase chain reaction. A prominent feature observed in infected fish were the petechial and ecchymotic haemorrhages on the body surface and in visceral organs, as well as serosanguinous ascites; however, many fish had few and subtle, gross lesions. Histologically, virtually all fish had a vasculitis and multifocal necrosis of numerous tissues. Excellent correlation was found between the presence of VHSV IVb antigen detected by immunohistochemistry and the pathological changes noted by light microscopy. Intact and degenerate leukocytes, including cells resembling lymphocytes and macrophages, also had cytoplasmic viral antigen. By contrast, renal tubules and gonadal tissues (ovary and testis), were strongly immunopositive for VHSV IVb, but no lesions were noted.

Entities:  

Mesh:

Year:  2011        PMID: 21381518     DOI: 10.3354/dao02285

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  8 in total

1.  In vivo and in vitro phenotypic differences between Great Lakes VHSV genotype IVb isolates with sequence types vcG001 and vcG002.

Authors:  Sierra M Imanse; Emily R Cornwell; Rodman G Getchell; Gael Kurath; Paul R Bowser
Journal:  J Great Lakes Res       Date:  2014-12-01       Impact factor: 2.480

2.  Lrcasp9 shares similarity in structural motifs with human caspase-9 and is activated following bacterial infection and anti-viral vaccination.

Authors:  Alok Kumar Giri; Mahismita Paichha; Ashis Saha; Surajit Das; Mrinal Samanta
Journal:  3 Biotech       Date:  2018-07-27       Impact factor: 2.406

Review 3.  Immunity to fish rhabdoviruses.

Authors:  Maureen K Purcell; Kerry J Laing; James R Winton
Journal:  Viruses       Date:  2012-01-18       Impact factor: 5.048

4.  Spread of the emerging viral hemorrhagic septicemia virus strain, genotype IVb, in Michigan, USA.

Authors:  Mohamed Faisal; Megan Shavalier; Robert K Kim; Elena V Millard; Michelle R Gunn; Andrew D Winters; Carolyn A Schulz; Alaa Eissa; Michael V Thomas; Martha Wolgamood; Gary E Whelan; James Winton
Journal:  Viruses       Date:  2012-05-03       Impact factor: 5.048

5.  Spontaneous peripheral neuritis in two electric eels (Electrophorus electricus).

Authors:  Nahid Rahman; Chiho Kezuka; Nobuyuki Higashiguchi; Naoya Kosaka; Takeshi Izawa; Jyoji Yamate; Mitsuru Kuwamura
Journal:  J Vet Med Sci       Date:  2019-03-05       Impact factor: 1.267

6.  Resistance to a rhabdovirus (VHSV) in rainbow trout: identification of a major QTL related to innate mechanisms.

Authors:  Eloi R Verrier; Michel Dorson; Stéphane Mauger; Corinne Torhy; Céline Ciobotaru; Caroline Hervet; Nicolas Dechamp; Carine Genet; Pierre Boudinot; Edwige Quillet
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

7.  Screening for viral hemorrhagic septicemia virus in marine fish along the Norwegian coastal line.

Authors:  Nina Sandlund; Britt Gjerset; Øivind Bergh; Ingebjørg Modahl; Niels Jørgen Olesen; Renate Johansen
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

8.  Susceptibility and Pathology in Juvenile Atlantic Cod Gadus morhua to a Marine Viral Haemorrhagic Septicaemia Virus Isolated from Diseased Rainbow Trout Oncorhynchus mykiss.

Authors:  Nina Sandlund; Renate Johansen; Ingrid U Fiksdal; Ann Cathrine B Einen; Ingebjørg Modahl; Britt Gjerset; Øivind Bergh
Journal:  Animals (Basel)       Date:  2021-12-10       Impact factor: 2.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.